Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.85 - $40.26 $817,965 - $1 Million
24,900 Added 85.57%
54,000 $2.05 Million
Q2 2024

Aug 14, 2024

SELL
$32.87 - $43.55 $200,506 - $265,655
-6,100 Reduced 17.33%
29,100 $973,000
Q1 2024

May 15, 2024

BUY
$37.88 - $43.77 $325,768 - $376,422
8,600 Added 32.33%
35,200 $1.5 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $95,130 - $116,850
3,000 Added 12.71%
26,600 $1.03 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $943,527 - $1.13 Million
23,600 New
23,600 $1.08 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $8.87 Million - $11.1 Million
-138,900 Reduced 84.9%
24,700 $1.59 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $12.1 Million - $13.7 Million
163,600 New
163,600 $13.2 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.